Sodium–glucose cotransporter 2 inhibitors in heart failure with preserved ejection fraction: A protocol for meta-analysis
Discussion:
This meta-analysis will evaluate the efficacy and safety of SGLT-2 inhibitors in HFpEF patients, providing evidence to the clinical use of SGLT-2 inhibitors in these patients.
Systematic review registration:
INPLASY2021120033
Source: Medicine - Category: Internal Medicine Tags: Research Article: Study Protocol Systematic Review Source Type: research
More News: Cardiology | Cardiovascular | Databases & Libraries | Diabetes | Endocrinology | Heart | Heart Failure | Internal Medicine | Renal Failure | Sports Medicine | Study | Urinary Tract Infections